Shuttle Pharmaceuticals Holdings, Inc. financial data

Symbol
SHPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
401 Professional Drive, Suite 260, Gaithersburg, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 230 % -75.4%
Debt-to-equity 125 % +315%
Return On Equity -583 % -415%
Return On Assets -259 % -198%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.23M shares -86.1%
Common Stock, Shares, Outstanding 2.95M shares -81.6%
Entity Public Float 11.7M USD
Common Stock, Value, Issued 29 USD -81.9%
Weighted Average Number of Shares Outstanding, Basic 2.38M shares +21%
Weighted Average Number of Shares Outstanding, Diluted 2.38M shares +21%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.34M USD +19.2%
General and Administrative Expense 1.28M USD +16.5%
Operating Income (Loss) -7.2M USD -40.1%
Nonoperating Income (Expense) -1.98M USD +21.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.78M USD -77.8%
Net Income (Loss) Attributable to Parent -9.19M USD -19.8%
Earnings Per Share, Basic -4.2 USD/shares +44.1%
Earnings Per Share, Diluted -4.2 USD/shares -74.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 157K USD -96%
Marketable Securities, Current 1.64M USD -43.4%
Accounts Receivable, after Allowance for Credit Loss, Current 5.95K USD
Other Assets, Current 81.5K USD
Assets, Current 361K USD -94.8%
Property, Plant and Equipment, Net 21.2K USD -21.1%
Operating Lease, Right-of-Use Asset 291K USD -17.6%
Other Assets, Noncurrent 6.48K USD
Assets 674K USD -90.9%
Liabilities, Current 1.66M USD +105%
Operating Lease, Liability, Noncurrent 256K USD -17.1%
Liabilities 1.99M USD +12.6%
Retained Earnings (Accumulated Deficit) -33M USD -38.6%
Stockholders' Equity Attributable to Parent -1.32M USD -123%
Liabilities and Equity 674K USD -90.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.24M USD +7.39%
Net Cash Provided by (Used in) Financing Activities -40K USD -101%
Net Cash Provided by (Used in) Investing Activities 101K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 2.95M shares -81.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.18M USD +5.62%
Interest Paid, Excluding Capitalized Interest, Operating Activities 79K USD
Deferred Tax Assets, Valuation Allowance 3.38M USD +161%
Deferred Tax Assets, Gross 3.43M USD +145%
Operating Lease, Liability 314K USD
Depreciation 1.91K USD +28.5%
Lessee, Operating Lease, Liability, to be Paid 383K USD
Property, Plant and Equipment, Gross 127K USD
Operating Lease, Liability, Current 58.7K USD -3.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 97.1K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 94.2K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 68.4K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 100K USD
Deferred Tax Assets, Operating Loss Carryforwards 1.73M USD +130%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 68.2K USD
Operating Lease, Payments 90.1K USD -25.6%
Additional Paid in Capital 31.7M USD +7.69%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 623K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%